🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Melinda G. Hollingshead

ORCID: 0000-0002-1207-1397

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.416Author DataRank

Indexed papers

6in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

Cancer Research(2024)10.1158/0008-5472.can-23-1349
Top 62%
0.222DataRank
Top 62%3 citations

Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +49 more

Papers

Driven by 21 papers — median percentile 0. Top paper: “DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors”.

DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors

Scientific Reports(2023)10.1038/s41598-023-32509-4
N/A
0.646DataRank · unranked
73 citations

Melinda G. Hollingshead, Dat Nguyen, Robert J. Kinders, James H. Doroshow, Sherry X. Yang +1 more

Isoform- and Phosphorylation-specific Multiplexed Quantitative Pharmacodynamics of Drugs Targeting PI3K and MAPK Signaling in Xenograft Models and Clinical Biopsies

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0566
N/A
0.475DataRank · unranked
11 citations

Casey L. Kilpatrick, Melinda G. Hollingshead, Dominic Esposito, Geraldine O’Sullivan Coyne, Andrea M. Gross +7 more

ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide

Oncotarget(2021)10.18632/oncotarget.28090
N/A
0.385DataRank · unranked
12 citations

Curtis Hose, John Connelly, Erik Harris, Anne Monks, Angie B. Dull +10 more

Phase 1 studies of the indenoisoquinolines LMP776 and LMP744 in patients with solid tumors and lymphomas

Cancer Chemotherapy and Pharmacology(2025)10.1007/s00280-025-04778-5
N/A
0.258DataRank · unranked
4 citations

Shivaani Kummar, Larry Rubinstein, Deborah Wilsker, Nancy Young Moore, Murielle Hogu +16 more

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

Cancer Research(2024)10.1158/0008-5472.can-23-1349
Top 62%
0.222DataRank
Top 62%3 citations

Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +49 more

ROADMAPS: An Online Database of Response Data, Dosing Regimens, and Toxicities of Approved Oncology Drugs as Single Agents to Guide Preclinical In Vivo Studies

Cancer Research(2022)10.1158/0008-5472.can-21-4151
Top 65%
0.194DataRank
Top 65%2 citations

Nathaniel Greenberg, Michelle Gottholm-Ahalt, Richard Camalier, Barry C. Johnson, Jerry M. Collins +2 more

A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.26.512745
Top 100%
0DataRank
Top 100%0 citations

X. Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +45 more

Exploiting Embryonic Niche Conditions to Grow Wilms Tumor Blastema in Culture

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.07.515473
N/A
0DataRank · unranked
0 citations

Harold N. Lovvorn, Melinda G. Hollingshead, Janene Pierce, Howard Stotler, Andrew J. Murphy +5 more

Exploiting embryonic niche conditions to grow Wilms tumor blastema in culture

Frontiers in Oncology(2023)10.3389/fonc.2023.1091274
N/A
0DataRank · unranked
1 citations

Harold N. Lovvorn, Melinda G. Hollingshead, Janene Pierce, Howard Stotler, Andrew J. Murphy +5 more

Data from Preclinical Modeling of a Phase 0 Clinical Trial: Qualification of a Pharmacodynamic Assay of Poly (ADP-Ribose) Polymerase in Tumor Biopsies of Mouse Xenografts

(2023)10.1158/1078-0432.c.6517116.v1
Top 100%
0DataRank
Top 100%0 citations

Melinda G. Hollingshead, Sonny Khin, Larry Rubinstein, Joseph E. Tomaszewski, James H. Doroshow +2 more

Data from F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

(2023)10.1158/1535-7163.c.6543264.v1
Top 100%
0DataRank
Top 100%0 citations

Donn G. Wishka, Omar D. Lopez, V. F. Rudchenko, Guangfei Huang, Sierra N. Hoffman +9 more

Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids

SLAS DISCOVERY(2025)10.1016/j.slasd.2025.100230
N/A
0DataRank · unranked
5 citations

Thomas S. Dexheimer, Thomas Silvers, Phillip R. Sanchez, Li Chen, Melinda G. Hollingshead +4 more

RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types

Cancer Research Communications(2025)10.1158/2767-9764.crc-24-0582
N/A
0DataRank · unranked
1 citations

Thomas S. Dexheimer, Nathan P. Coussens, Thomas Silvers, Raymond G. Fox, Samantha B. Kemp +7 more

Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models

Frontiers in Oncology(2025)10.3389/fonc.2025.1571635
N/A
0DataRank · unranked
1 citations

Sergio Y. Alcoser, MICHAEL E. MULLENDORE, Li Chen, Chih-Jian Lih, Vishnuprabha Rahul Kannan +18 more

Genomic characterization of preclinical models derived from primary and metastatic sites from rapid autopsy patients in PDMR.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e13506
Top 100%
0DataRank
Top 100%0 citations

Rajesh Patidar, Biswajit Das, Yvonne A. Evrard, Chris Karlovich, Tomas Vilimas +15 more

Targeted therapy combinations with ipatasertib in multi-cell type 3D tumor spheroid models

Academia oncology.(2025)10.20935/acadonco7726
N/A
0DataRank · unranked
0 citations

Naoko Takebe, Thomas S. Dexheimer, Thomas Silvers, Nathan P. Coussens, Melinda G. Hollingshead +2 more

Discovery and Optimization of 2H-1λ2-Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00019
N/A
0DataRank · unranked
29 citations

Karavadhi Surendra, Rajan Pragani, Li Liu, Yuhong Fang, Weihe Zhang +28 more

TET2 and DNMT3A mutations and exceptional response to 4′-thio-2′-deoxycytidine in human solid tumor models

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01091-5
N/A
0DataRank · unranked
12 citations

Melinda G. Hollingshead, Larry Rubinstein, Dat Nguyen, Angelo B. A. Larenjeira, Robert J. Kinders +3 more

F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-20-0738
N/A
0DataRank · unranked
11 citations

Donn G. Wishka, Omar D. Lopez, V. F. Rudchenko, Guangfei Huang, Sierra N. Hoffman +9 more

Development and validation of an LC–MS/MS generic assay platform for small molecule drug bioanalysis

Journal of Pharmaceutical and Biomedical Analysis(2021)10.1016/j.jpba.2021.114185
N/A
0DataRank · unranked
7 citations

Joseph M. Covey, Melinda G. Hollingshead, Apurva K. Srivastava, Timothy W. Synold, Jan H. Beumer +1 more

3'-[18F]fluoro-3'-deoxythymidine ([18F]FLT) Positron Emission Tomography as an In Vivo Biomarker of inhibition of CDK 4/6-Rb pathway by Palbociclib in a patient derived bladder tumor

Journal of Translational Medicine(2022)10.1186/s12967-022-03580-8
N/A
0DataRank · unranked
5 citations

Joseph D. Kalen, Paula Jacobs, Lisa Riffle, Amy James, Lai Thang +6 more